S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Better Than Oil Stocks (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
BREAKING: Tiny biotech successfully treats blindness (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
BREAKING: Tiny biotech successfully treats blindness (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Better Than Oil Stocks (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
BREAKING: Tiny biotech successfully treats blindness (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
BREAKING: Tiny biotech successfully treats blindness (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Better Than Oil Stocks (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
BREAKING: Tiny biotech successfully treats blindness (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
BREAKING: Tiny biotech successfully treats blindness (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Better Than Oil Stocks (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
BREAKING: Tiny biotech successfully treats blindness (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
BREAKING: Tiny biotech successfully treats blindness (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture

Alzamend Neuro (ALZN) Short Interest Ratio & Short Volume

$0.90
+0.01 (+1.13%)
(As of 02/23/2024 ET)

Alzamend Neuro Short Interest Data

Current Short Volume
42,300 shares
Previous Short Volume
72,300 shares
Change Vs. Previous Month
-41.49%
Dollar Volume Sold Short
$36,378.00
Short Interest Ratio / Days to Cover
0.3
Last Record Date
January 31, 2024
Outstanding Shares
7,120,000 shares
Float Size
4,550,000 shares
Short Percent of Float
0.93%
Today's Trading Volume
23,468 shares
Average Trading Volume
22,579 shares
Today's Volume Vs. Average
104%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Alzamend Neuro ?

Sign up to receive the latest short interest report for Alzamend Neuro and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ALZN Short Interest Over Time

ALZN Days to Cover Over Time

ALZN Percentage of Float Shorted Over Time


Alzamend Neuro Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202442,300 shares $36,378.00 -41.5%0.9%0.3 $0.86
1/15/202472,300 shares $70,449.12 -2.8%1.9%0.5 $0.97
12/31/202374,400 shares $66,216.00 -43.5%2.1%0.6 $0.89
12/15/2023131,700 shares $131,700.00 -29.5%3.7%1 $1.00
11/30/2023186,900 shares $226,149.00 +379.2%5.7%1.6 $1.21
11/15/202339,000 shares $58,500.00 -18.2%1.2%0.4 $1.50
10/31/202347,700 shares $1.25 million -92.1%1.5%2.3 $26.26
10/15/2023602,000 shares $124,012.00 +30.0%1.2%2.8 $0.21
9/30/2023463,200 shares $109,778.40 +82.8%1.0%2.2 $0.24
9/15/2023253,400 shares $60,816.00 +17.3%0.5%1.3 $0.24
8/31/2023216,000 shares $56,635.20 -60.7%0.4%1.2 $0.26
8/15/2023549,900 shares $169,919.10 +8.9%1.2%2.8 $0.31
7/31/2023505,200 shares $228,855.60 +2.6%1.1%3 $0.45
7/15/2023492,500 shares $247,235.00 +4.0%1.1%3.1 $0.50
6/30/2023473,700 shares $241,587.00 +13.0%1.1%2.9 $0.51
6/15/2023419,400 shares $285,192.00 -44.9%0.9%2.5 $0.68
5/31/2023761,400 shares $552,928.68 +44.0%1.7%4.2 $0.73
5/15/2023528,600 shares $274,713.42 -11.1%1.2%3.2 $0.52
4/30/2023594,400 shares $325,315.12 -8.6%1.3%3.5 $0.55
4/15/2023650,500 shares $382,038.65 +10.9%1.4%3.4 $0.59
3/31/2023586,500 shares $249,262.50 -18.2%1.3%2.9 $0.43
3/15/2023717,000 shares $343,729.80 -0.4%1.6%2.4 $0.48
2/28/2023719,600 shares $386,353.24 +5.1%1.6%2.4 $0.54
2/15/2023685,000 shares $401,478.50 -31.1%1.5%2.2 $0.59
1/31/2023994,100 shares $659,784.17 +11.2%2.2%2.8 $0.66
1/15/2023893,700 shares $529,964.10 -44.8%2.0%2.5 $0.59
12/30/20221,620,000 shares $915,138.00 +3.2%4.5%4.4 $0.56
12/15/20221,570,000 shares $1.40 million -7.7%4.4%3.6 $0.89
11/30/20221,700,000 shares $1.96 million -20.6%5.8%3.3 $1.15
11/15/20222,140,000 shares $2.40 million +27.4%7.3%4 $1.12
10/31/20221,680,000 shares $1.97 million -11.1%5.4%2.9 $1.17
10/15/20221,890,000 shares $1.98 million -34.2%5.5%3.1 $1.05
9/30/20222,870,000 shares $3.42 million +221.9%8.4%4.8 $1.19
9/15/2022891,700 shares $1.11 million -33.0%2.6%1.9 $1.24
8/31/20221,330,000 shares $1.20 million +112.9%3.9%3.7 $0.91
8/15/2022624,800 shares $649,792.00 -40.5%1.8%1.6 $1.04
7/31/20221,050,000 shares $933,555.00 -10.3%3.4%2.9 $0.89
7/15/20221,170,000 shares $1.09 million +17.2%4.0%2.3 $0.93
6/30/2022998,700 shares $863,276.28 -4.9%3.5%1.4 $0.86
6/15/20221,050,000 shares $888,300.00 -37.9%3.6%1.2 $0.85













ALZN Short Interest - Frequently Asked Questions

What is Alzamend Neuro's current short interest?

Short interest is the volume of Alzamend Neuro shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 42,300 shares of ALZN short. 0.93% of Alzamend Neuro's shares are currently sold short. Learn More on Alzamend Neuro's current short interest.

Which institutional investors are shorting Alzamend Neuro?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Alzamend Neuro: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Alzamend Neuro?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.93% of Alzamend Neuro's floating shares are currently sold short.

Is Alzamend Neuro's short interest increasing or decreasing?

Alzamend Neuro saw a drop in short interest in the month of January. As of January 31st, there was short interest totaling 42,300 shares, a drop of 41.5% from the previous total of 72,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Alzamend Neuro's float size?

Alzamend Neuro currently has issued a total of 7,120,000 shares. Some of Alzamend Neuro's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Alzamend Neuro currently has a public float of 4,550,000 shares.

How does Alzamend Neuro's short interest compare to its competitors?

0.93% of Alzamend Neuro's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Alzamend Neuro: Genprex, Inc. (3.72%), Aptorum Group Limited (0.15%), Pulmatrix, Inc. (0.17%), Kazia Therapeutics Limited (1.11%), Shuttle Pharmaceuticals Holdings, Inc. (1.55%), GT Biopharma, Inc. (0.06%), Lipella Pharmaceuticals Inc. (0.22%), Hillstream BioPharma, Inc. (0.42%), Hoth Therapeutics, Inc. (2.63%), Cyclerion Therapeutics, Inc. (1.44%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Alzamend Neuro stock?

Short selling ALZN is an investing strategy that aims to generate trading profit from Alzamend Neuro as its price is falling. ALZN shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Alzamend Neuro?

A short squeeze for Alzamend Neuro occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALZN, which in turn drives the price of the stock up even further.

How often is Alzamend Neuro's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALZN, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ALZN) was last updated on 2/24/2024 by MarketBeat.com Staff